Trademark: 88174433
Word
TCR² THERAPEUTICS
Status Date
Tuesday, October 22, 2019
Registration Number
5892910
Registration Date
Tuesday, October 22, 2019
Filing Date
Tuesday, October 30, 2018
Published for Opposition
Tuesday, April 30, 2019
5 Biological and pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use in the nature of biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases
42 Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
Color is not claimed as a feature of the mark.
"TCR THERAPEUTICS"
The mark consists of four shaded oblongs centered above six shaded oblongs of the same size. The oblongs are to the left of the wording "TCR THERAPEUTICS" in stylized characters displayed on two lines with a "2" in stylized characters forming an exponent over "TCR".
Oct 22, 2019
Registered-Principal Register
Sep 18, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 17, 2019
Allowed Principal Register - Sou Accepted
Sep 13, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 12, 2019
Statement Of Use Processing Complete
Sep 9, 2019
Use Amendment Filed
Sep 12, 2019
Extension 1 Granted
Sep 9, 2019
Extension 1 Filed
Sep 12, 2019
Case Assigned To Intent To Use Paralegal
Sep 9, 2019
Teas Extension Received
Sep 9, 2019
Teas Statement Of Use Received
Jun 25, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 30, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 30, 2019
Published For Opposition
Apr 10, 2019
Notification Of Notice Of Publication E-Mailed
Mar 26, 2019
Law Office Publication Review Completed
Mar 26, 2019
Approved For Pub - Principal Register
Mar 21, 2019
Teas/Email Correspondence Entered
Mar 20, 2019
Correspondence Received In Law Office
Mar 20, 2019
Teas Response To Office Action Received
Feb 18, 2019
Notification Of Non-Final Action E-Mailed
Feb 18, 2019
Non-Final Action E-Mailed
Feb 18, 2019
Non-Final Action Written
Feb 6, 2019
Assigned To Examiner
Jan 31, 2019
Applicant Amendment Prior To Examination - Entered
Jan 29, 2019
Assigned To Lie
Jan 25, 2019
Teas Voluntary Amendment Received
Nov 15, 2018
Notice Of Design Search Code E-Mailed
Nov 14, 2018
New Application Office Supplied Data Entered In Tram
Nov 2, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
